Regeneron Pharmaceuticals, Inc.

KBC Group NV REGN
Report date
9/30/2026
Quarter
2026 Q3
Filed
10/22/2026
Shares
188,496
Value ($000)
142,930
Weight
0.3%
2013 Q4 - 2026 Q3 (9 filings)
Shares History
History scope: non-option holdings only (PUT/CALL rows excluded).